The itch world woke up on 🔥 this morning with the FDA approval of #nemolizumab for #prurigo nodularis (PN). It was an honor to serve as the lead investigator of the Olympia program resulting in a breakthrough therapy for #PN patients https://t.co/TS9iL473a0 #dermtwitter#itch
A new study finds that GBP3 promotes resistance of @glioblastoma cells to termozolomide through enhancing DNA damage repair. Read more in @oncogenejournal https://t.co/8O0103uwVi
FEBRUARY ISSUE: Prognostic Value of Tumor Volume in @Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.https://t.co/CMDt3PY8Wv
Excellent work by #Howard Fine's lab on cerebral organoids (GLICO) to model cellular states in @glioblastoma.
Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas. https://t.co/ipjZAHF9nF